Danos Olivier has filed 11 insider transactions across 1 company since June 2022.
Most recent transaction: a tax payment of 5452 shares of REGENXBIO Inc. ($RGNX) on February 01, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 1, 2025 | REGENXBIO Inc. | $RGNX | Danos Olivier | Chief Scientific Officer | F | Common Stock | 5452 | $8.07 | 226,348.0000 | 49,509,000 | 2.35% | 0.01% |
| Jan. 2, 2025 | REGENXBIO Inc. | $RGNX | Danos Olivier | Chief Scientific Officer | F | Common Stock | 12630 | $7.73 | 172,453.0000 | 49,509,000 | 6.82% | 0.03% |
| Jan. 2, 2025 | REGENXBIO Inc. | $RGNX | Danos Olivier | Chief Scientific Officer | A | Common Stock | 59347 | $0.00 | 231,800.0000 | 49,509,000 | 34.41% | 0.12% |
| Jan. 2, 2025 | REGENXBIO Inc. | $RGNX | Danos Olivier | Chief Scientific Officer | A | Stock Options (Right to buy) | 95721 | $0.00 | 95,721.0000 | 49,509,000 | 9999.99% | 0.19% |
| June 28, 2024 | REGENXBIO Inc. | $RGNX | Danos Olivier | Chief Scientific Officer | A | Common Stock | 1363 | $9.95 | 126,216.0000 | 43,734,000 | 1.09% | 0.00% |
| Aug. 1, 2024 | REGENXBIO Inc. | $RGNX | Danos Olivier | Chief Scientific Officer | A | Common Stock | 58867 | $0.00 | 185,083.0000 | 43,734,000 | 46.64% | 0.13% |
| June 30, 2022 | REGENXBIO Inc. | $RGNX | Danos Olivier | Chief Scientific Officer | A | Common Stock | 728 | $21.00 | 93,678.0000 | 0 | 0.78% | 0.00% |
| June 30, 2023 | REGENXBIO Inc. | $RGNX | Danos Olivier | Chief Scientific Officer | A | Common Stock | 1123 | $16.99 | 94,801.0000 | 43,152,000 | 1.20% | 0.00% |
| Jan. 2, 2024 | REGENXBIO Inc. | $RGNX | Danos Olivier | Chief Scientific Officer | F | Common Stock | 8410 | $17.95 | 86,391.0000 | 43,734,000 | 8.87% | 0.02% |
| Jan. 2, 2024 | REGENXBIO Inc. | $RGNX | Danos Olivier | Chief Scientific Officer | A | Common Stock | 38462 | $0.00 | 124,853.0000 | 43,734,000 | 44.52% | 0.09% |
| Jan. 2, 2024 | REGENXBIO Inc. | $RGNX | Danos Olivier | Chief Scientific Officer | A | Stock Options (Right to buy) | 61050 | $0.00 | 61,050.0000 | 43,734,000 | 9999.99% | 0.14% |